iAnthus Announces Revocation of Cease Trade Order
NEW YORK, NY and TORONTO, ON – August 17, 2020 – iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQX: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, announces that on August 14, 2020, the Ontario Securities Commission issued a full revocation of the cease trade order (the “CTO”) which was originally issued on June 22, 2020.
The CTO was issued due to the Company’s failure to meet a deadline to file: (i) annual audit financial statements, (ii) the associated management’s discussion and analysis, and (iii) certification of annual filings for the financial year ended December 31, 2019 (collectively, the “Annual Filings”).
The Company filed the Annual Filings on July 31, 2020, but the CTO remained in place due to the Company’s failure to meet a deadline to file: (i) interim financial statements, (ii) the associated management’s discussion and analysis, and (iii) certification of interim filings for the interim period ended March 31, 2020 (collectively, the “Interim Filings”). The Company filed the Interim Filings on August 14, 2020, and the CTO has now been fully revoked. Copies of the Annual Filings and the Interim Filings are available under the Company’s SEDAR profile at www.sedar.com.
The Company is coordinating with the Canadian Securities Exchange (“CSE”) with respect to reinstatement of trading on the CSE. The Company expects to provide further updates on reinstatement of trading pursuant to a separate news release.
About iAnthus
iAnthus owns and operates licensed cannabis cultivation, processing and dispensary facilities throughout the United States, providing investors diversified exposure to the U.S. regulated cannabis industry. Founded by entrepreneurs with decades of experience in operations, investment banking, corporate finance, law and healthcare services, iAnthus provides a unique combination of capital and hands-on operating and management expertise. iAnthus currently has a presence in 11 states and operates 36 dispensaries (AZ-4, MA-1, MD-3, FL-16, NY-3, CO-1, VT-1 and NM-7 where iAnthus has minority ownership). For more information, visit www.iAnthus.com.
COVID-19 Risk Factor
The Company may be impacted by business interruptions resulting from pandemics and public health emergencies, including those related to COVID-19. An outbreak of infectious disease, a pandemic, or a similar public health threat, such as the recent outbreak of COVID-19, or a fear of any of the foregoing could adversely impact the Company by causing operating, manufacturing, supply chain, and project development delays and disruptions, labor shortages, travel, and shipping disruption and shutdowns (including as a result of government regulation and prevention measures). It is unknown whether and how the Company may be affected if such a pandemic persists for an extended period of time, including as a result of the waiver of regulatory requirements or the implementation of emergency regulations to which the Company is subject. Although the Company has been deemed essential and/or has been permitted to continue operating its facilities in the states in which it cultivates, processes, manufactures, and sells cannabis during the pendency of the COVID-19 pandemic, there is no assurance that the Company’s operations will continue to be deemed essential and/or will continue to be permitted to operate. The Company may incur expenses or delays relating to such events outside of its control, which could have a material adverse impact on its business, operating results, financial condition, and the trading price of the Common Shares.
Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties, including concerning COVID-19 and the specific factors disclosed here and elsewhere in iAnthus’ periodic filings with Canadian securities regulators. When used in this news release, words such as "will”, “hope”, “could”, “plan”, “estimate”, “expect”, “intend”, “may”, “potential”, “believe”, “should”, “our vision" and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements relating to the reinstatement of trading on the CSE.
Readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. iAnthus disclaims any intention or obligation to update or revise such information, except as required by applicable law, and iAnthus does not assume any liability for disclosure relating to any other company mentioned herein.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
The securities to be issued pursuant to the Restructuring Transaction have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws and may not be offered or sold within the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws, or an exemption from such registration is available. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities. “United States” and “U.S. person” are as defined in Regulation S under the U.S. Securities Act.
CONTACT INFORMATION
Corporate/Media/Investors:
Julius Kalcevich, CFO
iAnthus Capital Holdings, Inc.
1-646-518-9411
investors@ianthuscapital.com
Laurel Hill Advisory Group
toll free at 1-877-452-7184 or 1-416-304-0211 or by email at assistance@laurelhill.com.
Released August 17, 2020